🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ahmed M. Elshazly

Kafrelsheikh University

ORCID: 0000-0003-0353-1643

Also affiliated with Virginia Commonwealth University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer”.

The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer

Frontiers in Oncology(2023)10.3389/fonc.2022.966441
N/A
0.483DataRank · unranked
24 citations

Ahmed M. Elshazly, Nipa Patel, Liliya Tyutyunyk‐Massey, Tammy H. Tran, Vishnu Kumarasamy +3 more

Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective

Autophagy Reports(2022)10.1080/27694127.2022.2155904
N/A
0DataRank · unranked
23 citations

Polina Wright, Jingwen Xu, David A. Gewirtz, Ahmed M. Elshazly

Is autophagy induction by PARP inhibitors a target for therapeutic benefit?

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics(2022)10.32604/or.2022.026459
N/A
0DataRank · unranked
21 citations

Tuong Vi V. Nguyen, David A. Gewirtz, Ahmed M. Elshazly

Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate Cancer

Cancers(2023)10.3390/cancers15205029
N/A
0DataRank · unranked
17 citations

David A. Gewirtz, Ahmed M. Elshazly

Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors

International Journal of Molecular Sciences(2023)10.3390/ijms241612669
N/A
0DataRank · unranked
10 citations

David A. Gewirtz, Ahmed M. Elshazly

The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies

International Journal of Molecular Sciences(2023)10.3390/ijms241914774
N/A
0DataRank · unranked
9 citations

David A. Gewirtz, Ahmed M. Elshazly

Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer

Frontiers in Endocrinology(2024)10.3389/fendo.2024.1298423
N/A
0DataRank · unranked
11 citations

Ali Abolhassani, Luke Guy, Ahmed M. Elshazly, John T. Barrett, Nahid F. Mivechi +3 more

A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research

Molecular Pharmacology(2024)10.1124/molpharm.124.000871
N/A
0DataRank · unranked
4 citations

Uruk Shahin, Sofian Al Shboul, David A. Gewirtz, Tareq Saleh, Ahmed M. Elshazly

A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy

International Journal of Molecular Sciences(2024)10.3390/ijms252111346
N/A
0DataRank · unranked
3 citations

Afshan Rahman, Ahmed M. Elshazly, Victoria Neely, Balaji Nagarajan, Glen E. Kellogg +3 more

Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer

Cancers(2022)10.3390/cancers14174289
N/A
0DataRank · unranked
26 citations

Ahmed M. Elshazly, Patricia V. Schoenlein, David A. Gewirtz, Ryan Finnegan

An overview of autophagy inhibition as a potential clinical strategy in cancer therapy

Molecular Pharmacology(2025)10.1016/j.molpha.2025.100056
N/A
0DataRank · unranked
5 citations

Nayyerehalsadat Hosseini, Aya A. Elzahed, David A. Gewirtz, Ahmed M. Elshazly